Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

6.26
Delayed Data
As of 3:59pm ET
 +0.25 / +4.16%
Today’s Change
1.51
Today|||52-Week Range
8.04
+206.86%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close6.01
Today’s open6.02
Day’s range6.02 - 6.27
Volume1,224,753
Average volume (3 months)2,850,239
Market cap$538.5M
Dividend yield--
Data as of 3:59pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+48.89%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ANIPANI Pharmaceuticals ...-0.14-0.30%
SYRSSyros Pharmaceutical...-0.75-3.72%
NTLAIntellia Therapeutic...+1.59+10.49%
MCRBSeres Therapeutics I...-0.13-1.00%
Data as of 4:00pm ET, 08/21/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts